Breaking News

Yearly Archives: 2021

Virginia DOE 9/11 sensitivity training video tells teachers to reject American exceptionalism

The us-regions Department of education” target=”_blank”>Education< terrorist attacks. Ahead of the 20th anniversary of 9/11, the VDOE posted a video on Friday training teachers about “culturally responsive and inclusive lessons” surrounding that day and how they can teach students about it “in a way that does not cause harm.” CALIFORNIA TEACHER BOASTS NOT …

Read More »

Pentagon denies reports military dogs were left in Afghanistan

The defense is denying reports that it left military” target=”_blank”>U.S. military<.  NON-PROFIT AIMING TO RESCUE DOZENS OF MILITARY DOGS FROM AFGHANISTAN: REPORT The nonprofit said in an early Tuesday tweet that “51 contracted military working dogs are safe & being cared for in their crates.” “There’s false information that we …

Read More »

Former British soldier plans Afghan escape with 400 evacuees in tow

A former world-regions soldier has plotted an escape from conflicts with hundreds of conflicts” target=”_blank”>refugees<.  MEDAL OF HONOR RECIPIENT LITTRELL: AFGHANISTAN FIASCO – DON’T PUNISH SERVICE MEMBERS FOR A LEADERSHIP FAILURE Slater helped evacuate dozens of people from Afghanistan during Britain’s airlifts, and he said he feels “massively let down” …

Read More »

Midterms loom: Republicans squeeze Dems over botched Afghanistan withdrawal

joe-biden” target=”_blank”>President Biden’s< and led U.S. allies to question American leadership – and it’s already becoming a central part of Republicans’ 2022 pitch to take back the house-of-representatives” target=”_blank”>House< “We had hoped to have an opportunity to be recognized to move a bill by veteran Mike Gallagher. It’s very simple …

Read More »

Antibody drug cuts moderate Alzheimer’s decline, Swiss biotech cautions over results

A Phase 2 trial involving an investigational monoclonal antibody drug, semorinemab, targeting the tau protein, reduced cognitive decline among adults with mild-to-moderate nervous-system-health disease by about 44%, Swiss biotech AC Immune announced Tuesday. Findings from the placebo-controlled study Lauriet stemmed from 272 adults with mild-to-moderate Alzheimer’s disease across 43 study sites …

Read More »